Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy

Kidney International

Volumn 53, Issue 4, 1998, Pages 918-925

  Bariéty, Jean ^a   Nochy, Dominique ^a   Mandet, Chantal ^a   Jacquot, Christian ^a   Glotz, Denis ^a   Meyrier, Alain ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Collapsing glomerulopathy; Fibrosis; Focal segmental glomerulosclerosis; Lambda cell transdifferentiation; Podocytes; Tubulointerstitial lesions

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; KIDNEY FAILURE; MALE; MICROSCOPY; NEPHROTIC SYNDROME; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL;

EID: 0031970078     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00845.x     Document Type: Article

References (67)

1. CAMERON JS: The enigma of focal segmental glomerulosclerosis. Kidney Int 50:S-119-S-131, 1996
2. CAMERON JS, TURNER DR, OGG CS, CHANTLER C, WILLIAMS DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218, 1978
3. RICH AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 100:173-186, 1957
4. CAMERON JS: The problem of focal segmental glomerulosclerosis, in Progress in Glomerulonephritis, edited by KINCAID-SMITH P, D'APICE AJ, ATKINS RC, New York, Wiley, 1979, p 209
5. HABIB R: Focal glomerular sclerosis. Kidney Int 4:355-361, 1973
6. RENNKE HG, KLEIN PS: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13:443-456, 1989
7. D'AGATI V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46:1223-1241, 1994
8. GREENBERG A, BASTACKY SI, IOBAL A, BOROCHOVITZ D, JOHNSON JP: Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: Clinicopathological correlations. Am J Kidney Dis 29:334-344, 1997
9. FOGO A, YOSHIDA Y, GLICK AD, HOMMA T, ICHIKAWA I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82:322-330, 1988
10. GLASSER RJ, VELLOSA JA, MICHAEL AF: Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis. Lab Invest 36:519-526, 1977
11. WHITESIDE CI, CAMERON R, MUNK S, LEVY J: Podocyte cytoskeletal disaggregation and basement-membrane detachment in puromycin aminonucleoside nephrosis. Am J Pathol 142:1641-1653, 1993
12. RYAN GB, KARNOVSKY MJ: An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis. Kidney Int 8:219-232, 1975
13. SAKEMI T, OHTSUKA N, TOMIYOSHI Y, MORITO F: Sex differences in progression of adriamycin-induced nephropathy in rats. Am J Nepherol 16:540-547, 1996
14. BERTANI T, ROCCHI G, SACCHI G, REMUZZI G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 7:12-29, 1986
15. OLSON JL, HEPTINSTALL RH: Nonimmunologic mechanisms of glomerular injury. Lab Invest 59:564-578, 1988
16. FLOEGE J, ALPERS CE, BURNS MW, PRITZI P, GORDON K, COUSER WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497, 1992
17. HOSTETTER TH, OLSON JL, RENNKE HG: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
18. KRIZ W, ELGER M, NAGATA M, KRETZLER M, UIKER S, KOEPPENHAGEMANN I, TENSCHERT S, LEMLEY KV: The role of podocytes in the development of glomerular sclerosis. Kidney Int 45(Suppl 45):S64-S72, 1994
19. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
20. FLOEGE J, JOHNSON RI, ALPERS CE, FATEMI-NAINI S, RICHARDSON CA, GORDON K, COUSER WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol 142:637-650, 1993
21. SHIRATO I, HOSSER H, KIMURA K, SAKAI T, TOMINO Y, KRITZ W: The development of focal segmental glomerulosclerosis in Masugi nephritis is based on progressive podocyte damage. Virchows Arch 429:255-273, 1996
22. BOLTON WK, WESTERVELT FBJ, STURGILE BC: Nephrotic syndrome and focal glomerular sclerosis in aging man. Nephron 20:307-315, 1978
23. HEUDES D, MICHEL O, CHEVALIER J, SCALBERT E, EZAN E, BARIETY J. ZIMMERMAN A, CORMAN B: Effect of chronic Ang 1-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am J Physiol 266: R1038-R1051, 1994
24. GRISHMAN E, CHURG J: Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes. Kidney Int 7:111-122, 1975
25. SCHWARTZ MM, LEWIS EJ: Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28:968-974, 1985
26. VERANI RR, HAWKINS EP: Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion. Am J Nephrol 6:263-270, 1986
27. SCHWARTZ MM, KORBET SM, RYDELL J, BOROK R, GENCHI R: Primary focal segmental glomerular sclerosis in adults: Prognostic value of histologic variants. Am J Kidney Dis 25:845-852, 1995
28. SCHWARTZ MM, KORBET SM: Primary focal segmental glomerulosclerosis: Pathology, histological variants, and pathogenesis. Am J Kidney Dis 22:874-883, 1993
29. YOSHIKAWA N, HIROSHI I, AKAMATSU R, HAZIKANO H, OKADA S, MATSUO T: Glomerular podocyte vacuolation in focal segmental glomerulosclerosis. Arch Pathol Lab Med 110:394-398, 1986
30. KORBERT SM, SCHWARTZ MM, LEWIS EJ: Recurrent nephrotic syndrome in renal allografts. Am J Kidney Dis 11:270-276, 1988
31. FRIES JWU, SANDSTROM DJ, MEYER TW, RENNKE HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60:205-218, 1989
32. NAGATA M, SCHÄRER K, KRIZ W: Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture. Kidney Int 42:136-147, 1992
33. NAGAIA M, KRIZ W: Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int 42:148-160, 1992
34. VALERI A, BARISONI L, APPEL GB, SEIGLE R, D'AGATI V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50:1734-1746, 1996
35. DETWILLER RK, FALK RJ, HOGAN SL, JENNETTE JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45:1416-1424, 1994
36. WEISS MA, DAQUIOAG E, MARGOLIN EG, POLLACK VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathologic entity? Am J Kidney Dis 7:720-728, 1986
37. MENDRICK DL, KELLY DM, RENNKE HG: Antigen processing and presentation by glomerular visceral epithelium in vitro. Kidney Int 39:71-78, 1991
38. ORIKASA M, IWANAGA T, TAKAHASHI-IWANAGA H, KOZIMA K, SHIMIZU F: Macrophagic cells outgrowth from normal rat glomerular culture: Possible metaplastic change from podocytes. Lab Invest 75:719-733, 1996
39. VASMANT D, MAURICE M, FELDMANN G: Cytoskeleton ultrastructure of podocytes and glomerular endothelial cells in man and in the rat. Anat Rec 210:17-24, 1984
40. RONCO PM, ARDAILLOU N, VERROUST P, LELONGT B: Pathophysiology of the podoeyte: A target and a major player in glomerulonephritis. Adv Nephrol 23:91-131, 1994
41. KAZATCHKINE MD, FEARON DT, APPAY MD, MANDET C, BARIÉTY J: Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal disease. Loss of C3b receptor in focal hyalinosis and in proliferative nephritis of systemic lupus crythematosus. J Clin Invest 69:900-912, 1982
42. COOK J, FISCHER E, BOUCHEIX C, MIRSRAHI M, JOUVIN MH, WEISS L, JACK RM, KAZATCHKINE MD: Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol 22:531-539, 1985
43. VERANT RR: Obesity-associated focal segmental glomerulosclerosis: Pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia. Am J Kidney Dis 20:629-634, 1992
44. D'AGATI V, APPEL GB: HIV infection and the kidney. J Am Soc Nephrol 8:138-152, 1997
45. KRIZ W: Progressive renal failure-Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
46. MCDONNELL MP, KASISKE BL, CLEARY MP, KEANE WF: Effects of genetic obesity on renal structure and function in the Zucker rat. IL Micropunctures studies. J Lab Clin Med 106:605-610, 1985
47. VERANI RR, HAWKINS EP: Recurrent focal segmental glomerulosclerosis: A pathological study of the early lesion. Am J Nephrol 6:263-270, 1986
48. KERJASCHKI D, SHARKEY DJ, FARQUHAR MG: Identification and characterization of podocalyxin-The major sialoglycoprotein of the glomerular epithelial cell. J Cell Biol 98:1591-1596, 1984
49. DRENCKHAHN D, FRANKE RP: Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat and man. Lab Invest 59:673-682, 1988
50. STRIKER GE, STRIKER LJ: Glomerular cell culture. Lab Invest 53:122-131, 1985
51. PULFORD KAF, SIPOS A, CORDELL JL, STROSS WP, MASON DY: Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 2:973-980, 1990
52. MICKLEM K, RIGNEY E, CORDELL J, SIMMONS D, STROSS P, TURLEY H, SEED B, MASON D: A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies. Br J Haematol 73:6-11, 1989
53. PULFORD KAF, RIGNEY EM, MICKLEM KJ, JONES M, STROSS WP, GATTER KC, MASON DY: KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42:414-421, 1989
54. SAITO N, PULFORD KAF, BRETON-GORIUS J, MASSÉ JM, MASON DY, CRAMER EM: Ultrastructural localization of the CD68 macrophage-associated antigen in human blood neutrophils and monocytes. Am J Pathol 139:1053-1059, 1991
55. FALINI B, FLENGHI L, PILERI S, GAMBACORTA M, BIGERNA B, DURKOP H, ET AL: PG-M1: A new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 142:1359-1372, 1993
56. TAKEYA M, OKUMURA K, TAKAHASHI K: A new group of mAb that recognize tissue macrophages but not freshly isolated blood monocytes, in Leucocyte Typing V. White Cell Differentiation Antigens, edited by SCHLOSSMAN SF, BOUMSELL L, GILKS W, HARLAN JM, KISHIMOTO T, MORIMOTO C, RITZ J, SHAW S, SILVERSTEIN R, SPRINGER T, TEDDER TF, TODD RF, Oxford, Oxford University Press, 1995, pp 1032-1034
57. PULFORD K, MICKLEM K, MCCARTHY S, CORDELL J, JONES M, MASON DY: A monocyte/macrophage antigen recognized by the four antibodies GH/61, Ber-MAC3, Ki-M8 and SM4. Imnumulogy 75:588-545, 1992
58. BACKÉ E, SCHWARTING R, GERDES J, ERNST M, STEIN H: Ber-MAC3: New monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J Clin Pathol 44:936-945, 1991
59. LAW SKA, MICKLEM KJ, SHAW JM, ZHANG XP, DONG Y, WILLIS AC, MASON DY: A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily. Eur J Immunol 23:2320-2325, 1993
60. CARBONE A, GLOGHINI A, VOLPE R, PINTO A: KP1 (CD68)-positive large cell lymphomas: A histopathologic and immunophenotypic characterization of 12 cases. Hum Pathol 24:886-896, 1993
61. GLOGHINI A, RIZZO A, ZANETTE I, CANAL B, RUPOLO G, BASSI P, CARBONE A: KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas. Am J Clin Pathol 103:425-431, 1995
62. TSANG WY, CHAN JK: KP1 (CD68) staining of granular cell neoplasma: Is KP1 a marker for lysosomes rather than the histiocytic lineage? Histopathology 21:84-86, 1992
63. HORNY H-P, SCHAUMBURG-LEVER G, BOLZ S, GEERTS ML, KAISERLING E: Use of monoclonal antibody KP1 for identifying normal and neoplastic human mast cells. J Clin Pathol 43:719-722, 1990
64. TOS AP, DOGLIONI C, LAURINO L, FLETCHER CD: KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker. Histopathology 23:185-187, 1993
65. KAISERLING E, XIAO JC, RUCK P, HORNY HP: Aberrant expression of macrophage-associated antigens (CD68 and Ki-MIP) by Schwann cells in reactive and neoplastic neural tissue. Light-and electron-microscopic findings. Mod Pathol 6:463-468, 1993
66. HORNY HP, RUCK P, XIAO JC, KAISERLING E: Immunoreactivity of normal and neoplastic human tissue mast cells with macrophage-associated antibodies, with special reference to the recently developed monoclonal antibody PG-M1. Hum Pathol 24:355-358, 1993
67. KAISERLING E, KRÖBER S, XIAO JC, SCHAMBURG-LEVER G: Angiomyolipoma of the kidney. Immunoreactivity with HMB-45. Light-and electron-microscopic findings. Histopathology 25:41-48, 1994